Efficacy of Natural Compounds in Neurodegenerative Disorders

Pranay Srivastava1, Rajesh Singh Yadav2

  • 1Developmental Toxicology Division, Indian Institute of Toxicology Research, 80, MG Marg, Lucknow, 226 001, UP, India.

Advances in Neurobiology
|September 22, 2016
PubMed

Insights

This study explores natural herbal extracts like Withania somnifera and Curcuma longa for treating neurodegenerative disorders. These plants show promise in reducing neurotoxicity through antioxidant and anti-inflammatory effects.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Herbal Medicine

Background:

  • Neurodegenerative disorders involve progressive central nervous system deterioration due to genetic and environmental factors.
  • Pathophysiology includes oxidative stress, inflammation, and impaired cellular pathways, leading to neuronal cell death.
  • Limited effective treatments necessitate exploring alternative therapeutic strategies.

Purpose of the Study:

  • To investigate the neuroprotective potential of selected natural plants against neurodegenerative disorders.
  • To explore the molecular targets of these herbs in ameliorating neurotoxicity.
  • To evaluate the efficacy of herbal extracts as complementary therapies.

Main Methods:

  • Review of preclinical and clinical studies on specific medicinal plants.
  • Analysis of anti-inflammatory and antioxidant properties of selected herbs.
  • Investigation of molecular mechanisms underlying neuroprotection.

Main Results:

  • Selected plants, including Withania somnifera, Bacopa monnieri, Curcuma longa, Centella asiatica, Ocimum sanctum, Nardostachys jatamansi, and Emblica officinalis, exhibit significant anti-inflammatory and antioxidant potential.
  • Evidence suggests these herbs can mitigate neurotoxicity in experimental models.
  • Active constituents may preserve neurotransmitter integrity and receptor function.

Conclusions:

  • Natural agents and herbal extracts show therapeutic promise for neurodegenerative disorders.
  • These herbs can serve as valuable alternatives or adjuncts to conventional treatments.
  • Further research into their active constituents and molecular targets is warranted.

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
793
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.8K